Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2014-08-26 Report Publication Anno…
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
Version PDF
Report Publication Announcement Classification · 99% confidence The document is explicitly titled "Communiqué de presse" (Press Release) and announces the company's upcoming participation in four investor conferences (Goldman Sachs, Trout Group, Kepler Cheuvreux, Bank of America). This type of announcement, detailing future investor relations events rather than releasing periodic financial results (ER) or providing detailed strategy documents (IP), fits best under a general regulatory announcement or communication category. Since it is not a formal report (like 10-K or IR) but an announcement about future events, and it doesn't fit specific categories like DIV, DIRS, or MANG, the most appropriate classification is Regulatory Filings (RNS) as a general corporate communication, or potentially Investor Presentation (IP) if the context implied materials would be presented, but here it is purely an announcement of attendance. Given the nature of announcing conference attendance, RNS (Regulatory Filings/General Announcement) is the safest fit, although it is closely related to investor relations activities. It is not an Earnings Release (ER) as it doesn't contain financial results, nor is it a Report Publication Announcement (RPA) as it announces attendance, not the publication of a specific report.
2014-08-26 French
Version PDF
Regulatory Filings Classification · 95% confidence The document is titled "Communiqué de presse" (Press Release) and announces the positive safety review conclusion from the DSMB (Data and Safety Monitoring Board) regarding the GFT505 clinical trial in NASH. This type of announcement, which communicates key operational or clinical updates outside of mandatory periodic financial filings (like 10-K or IR), typically falls under general regulatory announcements or specific operational updates. Since it is a press release announcing a clinical trial milestone (DSMB reiterating favorable opinion), it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a specific operational update. Given the options, it most closely resembles a general regulatory announcement or a specific operational update. Since there isn't a specific code for 'Clinical Trial Update', and it is a formal announcement released to the public via press release, it fits best as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the news directly impacts financing, but RNS is the most appropriate fallback for non-standard, timely announcements. However, looking closely at the definitions, it is a press release announcing a significant operational/clinical event. If we consider the nature of the information (a clinical trial safety update), it is a specific piece of company news. Since it is a press release and not a formal statutory filing like 10-K or IR, RNS (Regulatory Filings - general regulatory announcements and fallback) is the most suitable category for this type of communication.
2014-06-27 French
PDF Version
Regulatory Filings Classification · 95% confidence The document is explicitly labeled as a "2014 Press release" and announces the recommendation from an independent Data and Safety Monitoring Board (DSMB) regarding the ongoing Phase 2b trial of GFT505. This type of announcement, detailing clinical trial progress and safety findings outside of a formal quarterly or annual financial report, is characteristic of an Earnings Release (ER) or a general regulatory/corporate update. Since it is a press release announcing a specific operational/clinical milestone rather than formal financial results (ER) or a general regulatory filing (RNS), and it doesn't fit other specific categories like M&A, Capital Change, or Director Dealing, the most appropriate classification is Earnings Release (ER) as it functions as a periodic operational update often released concurrently with or near earnings periods, or Regulatory Filing (RNS) as a general announcement. Given the content focuses on clinical trial status and safety, which is often a key component of investor relations updates, ER is a strong candidate if it were financial results, but since it's purely clinical progress, RNS (Regulatory Filings - general announcement) is a safer fallback. However, many companies issue press releases about clinical milestones that are categorized as ERs if they are periodic updates. Let's re-evaluate the definitions. It is not a full financial report (10-K, IR), nor a presentation (IP), nor a transcript (CT). It is a formal announcement of a significant operational event. Since it is a press release announcing a clinical trial update, and not a formal financial report, it fits best under the general Regulatory Filings (RNS) category, as it is a non-standard, non-financial-specific announcement. Upon closer inspection, the document is a standard press release format. While it discusses clinical trial progress, it is not an Earnings Release (ER) which typically focuses on financial performance metrics (revenue, EPS, etc.). It is a specific corporate update. Therefore, the fallback category, Regulatory Filings (RNS), is the most suitable classification for a non-standard, non-financial-specific corporate announcement.
2014-06-27 English
Version PDF
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated June 26, 2014, announcing the settlement and delivery of a private placement (placement privé) raising 49.7 million euros. Key phrases include "REGLEMENT-LIVRAISON DU PLACEMENT PRIVE" and "L'augmentation de capital a été souscrite". This clearly relates to a financing activity or capital structure change. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it specifically covers company fundraising and financing activities.
2014-06-26 French
PDF Version
Capital/Financing Update Classification · 99% confidence The document is explicitly labeled as a "Press release" dated June 26, 2014, announcing the "CLOSING OF THE EUR 49.7 MILLION PRIVATE PLACEMENT". This announcement details a capital increase transaction involving the issuance of new shares to qualified investors. This activity directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate finance event.
2014-06-26 English
Version PDF
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "Communiqué de presse" (Press Release) dated June 23, 2014. The core subject is GENFIT raising 49.7 million Euros through a private placement ("placement privé"). This action involves the issuance of new shares and discusses capital structure changes and fundraising activities. This directly aligns with the definition of 'Capital/Financing Update' (CAP). Although it is a press release, the content is substantive financial news (a capital raise), not merely an announcement about the publication of another report (which would suggest RPA or RNS). Therefore, CAP is the most appropriate classification.
2014-06-23 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.